From BugSigDB

A disease caused by infection with severe acute respiratory syndrome coronavirus 2.
  • 2019 novel coronavirus
  • 2019 novel coronavirus infection
  • 2019-nCoV
  • 2019-nCoV infection
  • beta-CoV
  • beta-CoVs
  • betacoronavirus
  • coronavirus disease 2019
  • SARS-coronavirus 2
  • SARS-CoV-2
  • severe acute respiratory syndrome coronavirus 2
  • severe acute respiratory syndrome coronavirus 2 infectious disease
  • β-coronavirus
  • β-CoV
  • β-CoVs
Studies related to COVID-19 Advanced search
16S rRNA gene sequencing of rectal swab in patients affected by COVID-19
Acute SARS-CoV-2 infection is associated with an expansion of bacteria pathogens in the nose including Pseudomonas Aeruginosa
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Alterations in the human oral and gut microbiomes and lipidomics in COVID-19
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza
Altered infective competence of the human gut microbiome in COVID-19
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization
Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18
Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection
Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19
Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients
Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19
Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases
Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19
Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai
Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever
Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery
Integrated gut virome and bacteriome dynamics in COVID-19 patients
Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing
Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge
Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19
Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients
Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19
Nasopharyngeal Microbiome Community Composition and Structure Is Associated with Severity of COVID-19 Disease and Breathing Treatment
Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?
Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study
SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition
SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome
Six-month follow-up of gut microbiota richness in patients with COVID-19
Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults
Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort
The active lung microbiota landscape of COVID-19 patients through the metatranscriptome data analysis
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort
The lower respiratory tract microbiome of critically ill patients with COVID-19
Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 +